about
The role of protein-tyrosine phosphatase 1B in integrin signalingMAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growthTumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivoExtracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophyHigh-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction.Noise propagation in two-step series MAPK cascadeInactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous systemAdvances in chemical carcinogenesis: a historical review and prospectiveERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenationCD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infectionExtracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosisEndosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosisCross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.An affinity-based fluorescence polarization assay for protein tyrosine phosphatasesSignaling pathway networks mined from human pituitary adenoma proteomics data.Mitogen-activated protein kinases in male reproductive functionDistinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2.Ser/thr phosphatases tonically attenuate the ERK-dependent pressor effect of ethanol in the rostral ventrolateral medulla in normotensive rats.Lose and gain: impacts of ERK5 and JNK cascades on each other.Exercise alters mRNA expression of telomere-repeat binding factor 1 in skeletal muscle via p38 MAPKCharacterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription.Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy.Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.Multiple signal pathways in obesity-associated cancer.The identification of raptor as a substrate for p44/42 MAPKThe role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.Death-associated protein kinase as a potential therapeutic target.Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomasTargeting the Raf kinase cascade in cancer therapy--novel molecular targets and therapeutic strategies.A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation.Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.Review article: mitogen-activated protein kinases in chronic intestinal inflammation - targeting ancient pathways to treat modern diseases.Phosphorylation of Raptor by p38beta participates in arsenite-induced mammalian target of rapamycin complex 1 (mTORC1) activation.Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes.JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
P2860
Q24301273-2393FC32-90FF-4AD1-B86B-5DAA76D4085DQ24547427-73F25306-4014-4590-A769-AF2E18A2B5ACQ24812465-58E5ABE2-723F-45C9-B544-9D6AEE6E7783Q26800200-D5F25BDD-AF3B-47D2-89BE-0371D7CD5237Q27863761-28018283-7BA9-45B4-98E7-08233CBF7AA5Q28483138-944B62EF-3857-4C10-B2BA-63D5E5F5F173Q28505561-3B8B5B4F-CCB0-4434-A4D2-A1882F0E384FQ28679143-C9CF9F11-9E50-4662-A525-6D902D3920AFQ28756544-EB45E353-A6BD-40D0-932F-EAF7EEEC3548Q28909786-9E53FCBD-7ED3-43BC-8491-F0DABF0778C9Q28910367-8F69E88F-51C9-432F-A281-C19218061D1DQ30478410-051DF70F-0FF3-4BC6-9194-62B36A60E01CQ30490506-6D0255FC-2816-4D51-A098-9231D85D047AQ30984991-6EA9CD7B-8DEF-4721-BDA0-56C30FD99E61Q33285970-2011913B-80CA-4AC6-9750-ED9F0A775636Q33567346-8AB573DB-381E-4ADB-8438-3210FED231BBQ33584135-C99CEBD8-0969-44F2-8AA7-CA6FDABC5CA6Q33812034-024AB5B9-E7D8-4F76-8F0E-96D89FF10CC9Q34021989-AE8DEF96-29DB-4A6A-B907-5370305F0BFAQ34072051-98997B9E-B674-4493-BC8B-701724DCCF03Q34435819-C009443E-9370-46C6-AC92-5573FE62C799Q34473579-56E016FB-5C79-4EEC-8A90-574DA2E0DAFAQ34473609-2A864FEB-920F-4AD5-A15F-A5A6B795B5C5Q34579680-DA099805-AA29-4ACF-ACED-0D5264E495B5Q34580311-B9830E95-6406-4DB1-94E4-10B631EF4EB8Q34598646-250F4273-D857-413B-810F-4C09CE0B802AQ34633750-6FED6D7C-001D-4805-BB65-92659DDFA6F6Q34696903-8F99723C-079A-4C38-B3F1-54E81A0CA8F5Q34771788-E5C78FA8-D229-4C87-A0FA-9AAFBFC6BBB2Q34837310-A93E245C-B05B-4156-9156-CD751E4E0DB6Q34998640-4C113F14-A6A7-4273-BBD6-AC71745B9AB0Q35020561-811FA9B1-EC3B-4D69-99FE-CEA86F159AF6Q35045356-BA5CA36F-221B-4CC9-A350-2B0A15796845Q35081944-1D68D199-3A3C-46E8-AA5D-E0B36185BD53Q35163934-5099BEF9-8619-4B94-BF2F-8508D9C049A0Q35166852-FADF33A6-C0F3-4AA5-AB44-ABE36884143EQ35171811-2E3A8E4B-5D51-4EA6-8024-9FA402C0F21DQ35213239-4651FA46-90CD-4E56-8D1D-A3CF58076E14Q35601422-B0AAD1F5-05C1-496F-B053-E09EF0A42F38Q35635353-78CB033A-DB9F-4719-9CEF-9F7AD564019C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacological inhibitors of MAPK pathways.
@ast
Pharmacological inhibitors of MAPK pathways.
@en
Pharmacological inhibitors of MAPK pathways.
@nl
type
label
Pharmacological inhibitors of MAPK pathways.
@ast
Pharmacological inhibitors of MAPK pathways.
@en
Pharmacological inhibitors of MAPK pathways.
@nl
prefLabel
Pharmacological inhibitors of MAPK pathways.
@ast
Pharmacological inhibitors of MAPK pathways.
@en
Pharmacological inhibitors of MAPK pathways.
@nl
P1476
Pharmacological inhibitors of MAPK pathways
@en
P2093
Jessie M English
P356
10.1016/S0165-6147(00)01865-4
P577
2002-01-01T00:00:00Z